- BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance
- Avalyn Pharma raises $175m in Series C financing for inhalation therapies
- NMD Pharma begins phase 2 trial for spinal muscular atrophy treatment
- Alfasigma to acquire Intercept Pharmaceuticals for $19 per share
- Regeneron and Sanofi’s sBLA for Dupixent accepted by FDA for priority review
- Acesion Pharma raises €45m series B funding
- CDC Advisory Committee recommends Pfizer’s RSV vaccine
- FDA approves Eli Lilly and Boehringer Ingelheim’s Jardiance for chronic kidney disease treatment
- FDA grants ODD to Nexcella’s NXC-201 as treatment for amyloid light chain amyloidosis
- AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan performs well in phase 3 trial
- Novo Nordisk partners with UNICEF to prevent global childhood obesity
- EC approves Menarini Group’s Orserdu for breast cancer treatment
- Pharmanovia acquires CNS portfolio from Sanofi
- Exscientia enters AI drug discovery collaboration with Merck KGaA
- EC approves Pfizer’s Litfulo for adolescents and adults with alopecia